127 related articles for article (PubMed ID: 3873303)
21. Extracorporeal perfusion of plasma over immobilized protein A in a patient with Kaposi's sarcoma and acquired immunodeficiency.
Kiprov DD; Lippert R; Jones FR; Lagios MD; Balint JP; Cohen RJ
J Biol Response Mod; 1984; 3(3):341-6. PubMed ID: 6379118
[TBL] [Abstract][Full Text] [Related]
22. T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi's sarcoma in AIDS.
Spornraft P; Fröschl M; Ring J; Meurer M; Goebel FD; Ziegler-Heitbrock HW; Riethmüller G; Braun-Falco O
Br J Dermatol; 1988 Jul; 119(1):1-9. PubMed ID: 3261596
[TBL] [Abstract][Full Text] [Related]
23. AIDS-Kaposi's sarcoma complex: evolution of a full-blown lymphologic syndrome.
Witte MH; Witte CL
Lymphology; 1988 Mar; 21(1):4-10. PubMed ID: 2456430
[TBL] [Abstract][Full Text] [Related]
24. [Kaposi's sarcoma and opportunistic infections in young patients without antecedents liable to involve immunodepression].
Presse Med; 1983 Nov; 12(39):2431-4. PubMed ID: 6227886
[TBL] [Abstract][Full Text] [Related]
25. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection.
Scorza Smeraldi R; Fabio G; Lazzarin A; Eisera NB; Moroni M; Zanussi C
Lancet; 1986 Nov; 2(8517):1187-9. PubMed ID: 2877328
[TBL] [Abstract][Full Text] [Related]
26. Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state.
Pitchenik AE; Fischl MA; Dickinson GM; Becker DM; Fournier AM; O'Connell MT; Colton RM; Spira TJ
Ann Intern Med; 1983 Mar; 98(3):277-84. PubMed ID: 6299151
[TBL] [Abstract][Full Text] [Related]
27. Clinical and immunological follow-up of patients with AIDS-associated Kaposi's sarcoma treated with an anti-IL-6 monoclonal antibody.
Racadot E; Audhuy B; Duvernoy H; Thyss A; Lang JM; Wijdenes J; Hervé P
Cytokines Mol Ther; 1995 Jun; 1(2):133-8. PubMed ID: 9384670
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma.
Modlin RL; Crissey JT; Rea TH
Int J Dermatol; 1983 Oct; 22(8):443-8. PubMed ID: 6315608
[No Abstract] [Full Text] [Related]
29. Tumor infiltrates in acquired immunodeficiency syndrome patients with Kaposi's sarcoma.
Cochran AJ; Nestor MS; Groopman JE; Ahmed AR
Lancet; 1983 Feb; 1(8321):416. PubMed ID: 6130406
[No Abstract] [Full Text] [Related]
30. Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti.
Pape JW; Liautaud B; Thomas F; Mathurin JR; St Amand MM; Boncy M; Pean V; Pamphile M; Laroche AC; Johnson WD
N Engl J Med; 1983 Oct; 309(16):945-50. PubMed ID: 6621622
[TBL] [Abstract][Full Text] [Related]
31. IgD production and other lymphocyte functions in HIV infection: immaturity and activation of B cells at different clinical stages.
Rogers LA; Forster SM; Pinching AJ
Clin Exp Immunol; 1989 Jan; 75(1):7-11. PubMed ID: 2784730
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of antibodies to HPV16-E7-protein does not differ between AIDS-patients with and without Kaposi's sarcoma.
Gross G; Pfister H; Wagner B; Brockmeyer N
Genitourin Med; 1994 Feb; 70(1):70-1. PubMed ID: 8300106
[No Abstract] [Full Text] [Related]
33. Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma.
Taylor J; Afrasiabi R; Fahey JL; Korns E; Weaver M; Mitsuysau R
Blood; 1986 Mar; 67(3):666-71. PubMed ID: 3081065
[TBL] [Abstract][Full Text] [Related]
34. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
35. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.
Marquart KH; Müller HA; Hartter P; Oku JC; Ayuko WO
J Trop Med Hyg; 1987 Apr; 90(2):93-4. PubMed ID: 3470530
[TBL] [Abstract][Full Text] [Related]
36. [Kaposi sarcoma in acquired immune deficiency syndrome (AIDS). I: Clinical findings and laboratory diagnosis].
Weidauer H; Hofmann H
Laryngol Rhinol Otol (Stuttg); 1985 Aug; 64(8):418-22. PubMed ID: 2995739
[TBL] [Abstract][Full Text] [Related]
37. Interferon inactivator(s) in patients with AIDS and AIDS-unrelated Kaposi's sarcoma.
Margolis DM
Am J Med; 1987 Jun; 82(6):1278. PubMed ID: 2440302
[No Abstract] [Full Text] [Related]
38. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
[TBL] [Abstract][Full Text] [Related]
39. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders.
Fahey JL; Prince H; Weaver M; Groopman J; Visscher B; Schwartz K; Detels R
Am J Med; 1984 Jan; 76(1):95-100. PubMed ID: 6229182
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of epidemic Kaposi's sarcoma. Implications for therapy.
Mitsuyasu RT; Taylor JM; Glaspy J; Fahey JL
Cancer; 1986 Apr; 57(8 Suppl):1657-61. PubMed ID: 3081246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
